Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, July 23, 2014
 
Register | Sign in
Home Page > Videos > Emerging Outsourcing Destinations: Pharmas Strategies and Growth Drivers
  Videos

Return

Emerging Outsourcing Destinations: Pharmas Strategies and Growth Drivers
JZMed

Jim Zhang, President, JZMed

Abstract
Emerging markets have been recognized as the key growth driver of the global pharmaceutical market.  They have thus received increasing attention from almost all drug companies around the world.  In addition to the attraction of the fast growing pharmaceutical market, the availability of a variety of outsourcing services at relatively low cost with increasing service capability and improved quality, is also attracting drug companies from all over the world to look for the outsourcing or collaboration opportunities in these countries, in particular China and India.  Currently, a large number of drug companies from all over the world are aggressively looking for partnerships with local companies or research organizations.  Meanwhile, to meet the high demand by the global drug companies and to position them well in these fast growing pharma outsourcing markets, almost all world major CROs and CMOs have made significant investments in these emerging countries.  This presentation will discuss in detail a series of new outsourcing strategies currently pursued by the global drug companies in these key emerging outsourcing countries and the strengths and weakness of the local service providers.

Request more information
Company product page



For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here

Scientific News
NIST Instrument Enables High-speed Chemical Imaging of Tissues
Researchers have demonstrated a dramatically improved technique for analyzing biological cells and tissues based on characteristic molecular vibration "signatures."
Transplanting Gene into Injured Hearts Creates Biological Pacemakers
Researchers develop first minimally invasive gene therapy procedure to treat heart rhythm disorders by transforming ordinary heart muscle cells into specialized rhythm-keeping cells, potentially eliminating future need for electronic pacemakers.
Common Gene Variants Account for Most Genetic Risk for Autism
Roles of heritability, mutations, environment estimated - NIH-funded study.
Using LC-MS to Analyse Sulfonamides in Food Grade Honey
Sulfonamides are one of a number of groups of chemicals whose presence in honey is limited by international regulations.
ChIP Sequencing Kit for Next Generation Sequencing
The assay kit from Porvair Sciences extends the benefits of their proprietary Chromatrap® solid state ChIP technology.
Illumina's HiSeq X Ten Sequencing Technology for Population Studies
Next-generation sequencing technologies to be implemented at new High-Throughput Genomics Center for the MENA region.
Foodborne Pathogen Detection Speeds Up Dramatically
Next-generation sequencing techniques allow rapidly identification of strains of salmonella, quickening responses to potential outbreaks.
Bowel Cancer Breakthrough May Benefit Thousands of Patients
Researchers at Queen’s University have discovered how two genes cause bowel cancer cells to become resistant to treatments used against the disease.
Innovative Technology Enables First Crystal Structure of mGlu5 Transmembrane Domain to be Determined
Several novel drug candidates have been identified to help treat specific neuropsychiatric disorders.
NIH Scientists Identify Gene Linked to Fatal Inflammatory Disease in Children
Repurposed drugs may offer first potential therapy.
Scroll Up
Scroll Down

Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv